Reaktion #612088

ord-2d0478087a3b4b2cbc0834917b29aa58

Reaktionsgleichung

CN1CCN(S(=O)(=O)C2CCN(c3c(F)cncc3Cl)CC2)CC1
1-[[1-(3-chloro-5-fluoro-4-pyridyl)-4-piperidyl]sulfonyl]-4-methyl-piperazine
O=C(O)C(F)(F)F
TFA
CC(C)(C)OC(N)=O
Tert-butyl carbamate
CC(C)(C)[O-].[Na+]
sodium tert-butoxide
COc1ccc(OC)c(P(C2CCCCC2)C2CCCCC2)c1-c1c(C(C)C)cc(C(C)C)cc1C(C)C
BrettPhos
CN1CCN(S(=O)(=O)C2CCN(c3c(N)cncc3F)CC2)CC1
5-fluoro-4-(4-((4-methylpiperazin-1-yl)sulfonyl)piperidin-1-yl)pyridin-3-amine

Lösungsmittel

Reaktionsbedingungen

Temperatur
80°CELSIUS
Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    TemperaturAfter 5 minutes at 80° C. the reaction was cooled to RT
  2. 2
    Sonstigepartitioned between ethyl acetate and water
  3. 3
    TrocknenThe combined organics was dried with MgSO4
  4. 4
    Einengenconcentrated in vacuo to a yellow solid
  5. 5
    SonstigeThe yellow solid was purified by column chromatography
  6. 6
    Waschento elute side products
  7. 7
    Waschen5-10% MeOH/DCM to elute product
  8. 8
    Einengenconcentrated in vacuo
  9. 9
    Sonstigeto yield a light yellow solid
  10. 10
    EinengenThe mixture was concentrated in vacuo

Vorschrift

Tert-butyl carbamate (211.3 mg, 1.804 mmol), sodium tert-butoxide (173.4 mg, 1.804 mmol), BrettPhos Pre-catalyst (143.7 mg, 0.1804 mmol) and BrettPhos (96.83 mg, 0.1804 mmol) were degassed by vacuum/nitrogen cycles (×5). A solution of 1-[[1-(3-chloro-5-fluoro-4-pyridyl)-4-piperidyl]sulfonyl]-4-methyl-piperazine (340 mg, 0.9022 mmol) in dry toluene (9.884 mL) was added and the resulting mixture was heated to 80° C. After 5 minutes at 80° C. the reaction was cooled to RT and partitioned between ethyl acetate and water. The combined organics was dried with MgSO4 and concentrated in vacuo to a yellow solid. The yellow solid was purified by column chromatography using 1% MeOH/DCM to elute side products and then 5-10% MeOH/DCM to elute product. Relevant fractions combined and concentrated in vacuo to yield a light yellow solid. It was dissolved in DCM (10 mL) followed by the addition of TFA (1.029 g, 695.3 μL, 9.022 mmol). The mixture was stirred at room temperature for 2 hours. The mixture was concentrated in vacuo to yield 5-fluoro-4-(4-((4-methylpiperazin-1-yl)sulfonyl)piperidin-1-yl)pyridin-3-amine as a light orange solid. MS (ES+) 358.1.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US09340546B2uspto-grants-2016_05